Literature DB >> 24323982

The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients.

Inge C Gyssens1, Winfried V Kern, David M Livermore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24323982      PMCID： PMC3856956          DOI： 10.3324/haematol.2013.091769

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  30 in total

Review 1.  Antimicrobial stewardship programs in health care systems.

Authors:  Conan MacDougall; Ron E Polk
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

2.  A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer.

Authors:  Murat Akova; Marianne Paesmans; Thierry Calandra; Claudio Viscoli
Journal:  Clin Infect Dis       Date:  2004-12-20       Impact factor: 9.079

3.  Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting: a follow-up study.

Authors:  S Sallah; J Y Wan; N P Nguyen; P Vos; G Sigounas
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

4.  Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance.

Authors:  H G Prentice; I M Hann; B Nazareth; P Paterson; A Bhamra; C C Kibbler
Journal:  Br J Haematol       Date:  2001-10       Impact factor: 6.998

5.  Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis.

Authors:  N A van Lent-Evers; R A Mathôt; W P Geus; B A van Hout; A A Vinks
Journal:  Ther Drug Monit       Date:  1999-02       Impact factor: 3.681

6.  The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

Authors:  J Klastersky; M Paesmans; E B Rubenstein; M Boyer; L Elting; R Feld; J Gallagher; J Herrstedt; B Rapoport; K Rolston; J Talcott
Journal:  J Clin Oncol       Date:  2000-08       Impact factor: 44.544

7.  European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.

Authors:  Diana Averbuch; Christina Orasch; Catherine Cordonnier; David M Livermore; Malgorzata Mikulska; Claudio Viscoli; Inge C Gyssens; Winfried V Kern; Galina Klyasova; Oscar Marchetti; Dan Engelhard; Murat Akova
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

8.  Experience with a once-daily dosing program of aminoglycosides in critically ill patients.

Authors:  S E Buijk; J W Mouton; I C Gyssens; H A Verbrugh; H A Bruining
Journal:  Intensive Care Med       Date:  2002-05-30       Impact factor: 17.440

9.  Discontinuation of intravenous antibiotic therapy during persistent neutropenia in patients receiving prophylaxis with oral ciprofloxacin.

Authors:  J J Cornelissen; M Rozenberg-Arska; A W Dekker
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

Review 10.  Diseases and drug-related interventions affecting host defence.

Authors:  S de Marie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267
View more
  25 in total

1.  Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).

Authors:  Cédric Bretonnière; Marc Leone; Christophe Milési; Bernard Allaouchiche; Laurence Armand-Lefevre; Olivier Baldesi; Lila Bouadma; Dominique Decré; Samy Figueiredo; Rémy Gauzit; Benoît Guery; Nicolas Joram; Boris Jung; Sigismond Lasocki; Alain Lepape; Fabrice Lesage; Olivier Pajot; François Philippart; Bertrand Souweine; Pierre Tattevin; Jean-François Timsit; Renaud Vialet; Jean Ralph Zahar; Benoît Misset; Jean-Pierre Bedos
Journal:  Intensive Care Med       Date:  2015-06-03       Impact factor: 17.440

Review 2.  Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients.

Authors:  Michael J Satlin; Thomas J Walsh
Journal:  Transpl Infect Dis       Date:  2017-10-25       Impact factor: 2.228

3.  Impact of antimicrobial stewardship programme on hospitalized patients at the intensive care unit: a prospective audit and feedback study.

Authors:  Maher R Khdour; Hussein O Hallak; Mamoon A Aldeyab; Mowaffaq A Nasif; Aliaa M Khalili; Ahamad A Dallashi; Mohammad B Khofash; Michael G Scott
Journal:  Br J Clin Pharmacol       Date:  2018-01-23       Impact factor: 4.335

4.  De-escalation and discontinuation strategies in high-risk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome.

Authors:  Giulia la Martire; Christine Robin; Nadia Oubaya; Raphaël Lepeule; Florence Beckerich; Mathieu Leclerc; Walid Barhoumi; Andréa Toma; Cécile Pautas; Sébastien Maury; Wiem Akrout; Catherine Cordonnier-Jourdin; Vincent Fihman; Mario Venditti; Catherine Cordonnier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-26       Impact factor: 3.267

Review 5.  The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies.

Authors:  Thomas M Baker; Michael J Satlin
Journal:  Leuk Lymphoma       Date:  2016-06-24

6.  The European Hematology Association Roadmap for European Hematology Research: a consensus document.

Authors:  Andreas Engert; Carlo Balduini; Anneke Brand; Bertrand Coiffier; Catherine Cordonnier; Hartmut Döhner; Thom Duyvené de Wit; Sabine Eichinger; Willem Fibbe; Tony Green; Fleur de Haas; Achille Iolascon; Thierry Jaffredo; Francesco Rodeghiero; Gilles Salles; Jan Jacob Schuringa
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

Review 7.  Bloodstream infections in neutropenic cancer patients: A practical update.

Authors:  Giulia Gustinetti; Malgorzata Mikulska
Journal:  Virulence       Date:  2016-04-02       Impact factor: 5.882

Review 8.  Bacterial Infections in Hematopoietic Stem Cell Transplant Recipients.

Authors:  Elisa Balletto; Małgorzata Mikulska
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-07-01       Impact factor: 2.576

Review 9.  The global threat of antimicrobial resistance: science for intervention.

Authors:  I Roca; M Akova; F Baquero; J Carlet; M Cavaleri; S Coenen; J Cohen; D Findlay; I Gyssens; O E Heuer; G Kahlmeter; H Kruse; R Laxminarayan; E Liébana; L López-Cerero; A MacGowan; M Martins; J Rodríguez-Baño; J-M Rolain; C Segovia; B Sigauque; E Tacconelli; E Wellington; J Vila
Journal:  New Microbes New Infect       Date:  2015-04-16

Review 10.  Surveillance of bloodstream infections in pediatric cancer centers - what have we learned and how do we move on?

Authors:  Arne Simon; Rhoikos Furtwängler; Norbert Graf; Hans Jürgen Laws; Sebastian Voigt; Brar Piening; Christine Geffers; Philipp Agyeman; Roland A Ammann
Journal:  GMS Hyg Infect Control       Date:  2016-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.